Items where Author is "Shahzamani, K."
![]() | Up a level |
(2025) Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers. Anti-cancer agents in medicinal chemistry. ISSN 1875-5992 (Electronic) 1871-5206 (Linking)
(2025) Role of phage therapy in acute gastroenteritis. Journal of Research in Medical Sciences. p. 11. ISSN 1735-1995
(2024) Evaluation of the effect of montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan; a randomized clinical trial. Journal of Nephropharmacology. ISSN 23454202 (ISSN)
(2024) Gut-Lung Microbiota Characterization in Patients with Non-Small Cell Lung Carcinoma and COVID-19 Coinfection. Archives of Iranian Medicine. pp. 62-71. ISSN 1029-2977
(2023) Different aspects in explaining how mutations could affect the binding mechanism of receptor binding domain of SARS-CoV-2 spike protein in interaction with ACE2. Plos One. p. 17. ISSN 1932-6203
(2023) A process evaluation of the Isfahan antibiotic awareness campaign: Developing engagement on antimicrobial resistance. Advanced Biomedical Research. p. 4. ISSN 2277-9175
(2022) Bioactivity assessments of phyco-assisted synthesized selenium nanoparticles by aqueous extract of green seaweed, <i>Ulva fasciata</i>. Emergent Materials. pp. 1689-1698. ISSN 2522-5731
(2021) Bio-inspired silver selenide nano-chalcogens using aqueous extract of Melilotus officinalis with biological activities. Bioresources and Bioprocessing.
(2021) Dysregulation of RNA interference components in COVID-19 patients. BMC RESEARCH NOTES. ISSN 1756-0500 J9 - BMC RES NOTES
(2021) Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Biomedicine & Pharmacotherapy. ISSN 0753-3322
(2021) Vaccine design and delivery approaches for COVID-19. INTERNATIONAL IMMUNOPHARMACOLOGY. ISSN 1567-5769 1878-1705 J9 - INT IMMUNOPHARMACOL


